Author/Authors :
Zaboli, Pardis Pharmaceutical Management and Economics Research Center - Tehran University of Medical Sciences - Tehran, Iran , Hashemi‑Meshkini, Amir Department of Pharmacoeconomics and Pharmaceutical Administration - Tehran University of Medical Sciences - Tehran, Iran , Varmaghani, Mehdi Department of Pharmacoeconomics and Pharmaceutical Administration - Tehran University of Medical Sciences - Tehran, Iran , Gholami, Hadi Department of Pharmaceutics - Tehran University of Medical Sciences - Tehran, Iran , Vazirian, Iman Department of Pharmaceutics - Tehran University of Medical Sciences - Tehran, Iran , Zekri, Hedieh‑Sadat Department of Economics - Shahid Beheshti University - Tehran, Iran , Eslamitabar, Shahriar Department of Pharmaceutics - Tehran University of Medical Sciences - Tehran, Iran , Kebriaeezadeh, Abbas Pharmaceutical Management and Economics Research Center - Tehran University of Medical Sciences - Tehran, Iran
Abstract :
The pharmaceutical legal framework is a very important infrastructure in achieving predefined goals in pharmaceutical sector: Accessibility, quality, and rational use of medicine. This study aims to review the current pharmaceutical sector-related legal provisions in Iran where the Food and Drug Organization (FDO) is in charge of regulating all issues related to the pharmaceutical sector. The main laws and regulations enacted by parliament and cabinet and even internal regulations enacted by the Ministry of Health or Iran FDO are reviewed. Different laws and regulations are categorized according to the main goals of Iran national drug policy.
Keywords :
Accessibility , availability , counterfeit medicines , pharmaceutical trade‑related aspects , rational use of medicine
